Logo Image
News
All NewsBlogs
Media
Around the Practice Between the LinesBreast Imaging in Focus with Manisha Bahl, MDImage IQInterventional Radiology in Focus with Mina Makary, MDMedical World NewsMolecular Imaging in Focus PodcastsRad-ViewShortsVideos
Conferences
Conference CoverageConference Listing
DI Executive
More
Resources
CME/CEE-booksEducationInteractive Tool KitsPartnersSponsored

Subscribe

  • News
  • Media
  • Conferences
  • DI Executive
  • Resources
  • Subscribe
  • AI
    • Technology
  • Breast Imaging
  • CT
    • Neurology CT
    • Cardiac CT
    • Women's Health CT
    • Oncology CT
  • Facility Management
    • Technology
  • MRI
    • Neurology MRI
    • Oncology MRI
    • Women's Health MRI
    • Cardiac MRI
  • Mammography
  • Molecular Imaging
  • Ultrasound
    • Women's Health Ultrasound
    • Oncology Ultrasound
    • Cardiac Ultrasound
  • X-Ray
    • Orthopedic X-Ray
Spotlight -
Breast Imaging|
RSNA|
Disease Spotlight: Prostate Cancer|
MRI|
Computed Tomography|
Molecular Imaging|
SNMMI
Advertisement

Siddharth Shah, Program Manager at Frost & Sullivan

Advertisement

Articles by Siddharth Shah, Program Manager at Frost & Sullivan

Artificial Intelligence: The Winner of the RSNA 2020

ByDr. Suresh Kuppuswamy, Industry Principal at Frost & Sullivan ,Siddharth Shah, Program Manager at Frost & Sullivan
January 5th 2021

Artificial intelligence topped the list of five major themes at RSNA 2020, highlighting all the developments from vendors this year.

Advertisement

Latest Updated Articles

  • Artificial Intelligence: The Winner of the RSNA 2020
    Artificial Intelligence: The Winner of the RSNA 2020

    January 5th 2021



Advertisement
Advertisement

Trending on Diagnostic Imaging

1

Mammography Study Shows Impact of AI-Powered Slab Reconstruction with DBT

2

GE HealthCare Unveils 4D Dynamic PET Imaging Software at SNMMI Conference

3

FDA Clears AI Ultrasound Software for Automated LVEF Calculation

4

Can AI Assessment of CT Attenuation Correction Mapping Be a Viable Alternative for CAC Risk Stratification?

5

SNMMI: What Early Research Reveals About the Alpha-Emitting Radioconjugate ATNM-400 for Prostate Cancer

  • Advertise
  • About
  • Contact Us
  • Editorial
  • Editorial Board
  • Do Not Sell My Personal Information
  • Privacy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us